Skip to main navigation

Skip to content

Global Need
- Vaccines
- History and Impact
Our Solution
Pipeline
About Us
- Our Mission
- Our Team
- Careers
- Contact
INVESTORS
Investor Relations

Quarterly Results

Quarterly Results

Show all

2018

Q3

Vaxart Announces Third Quarter 2018 Financial Results and Provides Corporate Update

Q2

Vaxart Announces Second Quarter 2018 Financial Results and Corporate Update

Q1

Aviragen Therapeutics Reports First Quarter of Fiscal Year 2018 Financial Results

2017

Q4

Aviragen Therapeutics Reports Fourth Quarter and Fiscal Year 2017 Financial Results

Q3

Aviragen Therapeutics Reports Third Quarter Fiscal Year 2017 Financial Results

Q2

Aviragen Therapeutics Reports Second Quarter Fiscal Year 2017 Financial Results

2016

Q4

Aviragen Therapeutics Reports Fourth Quarter and Fiscal Year 2016 Financial Results

Q3

Aviragen Therapeutics Reports Third Quarter Fiscal Year 2016 Financial Results

Q2

Biota Pharmaceuticals Reports Second Quarter Fiscal Year 2016 Financial Results

Q1

Biota Pharmaceuticals Reports First Quarter Fiscal Year 2016 Financial Results

2015

Q4

Biota Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2015 Financial Results

Q3

Biota Pharmaceuticals Reports Third Quarter Fiscal Year 2015 Financial Results

Q2

Biota Pharmaceuticals Reports Second Quarter Fiscal Year 2015 Financial Results

Q1

Biota Pharmaceuticals Reports First Quarter Fiscal Year 2015 Financial Results

2014

Q4

Biota Pharmaceuticals Reports Fourth Quarter and Fiscal Year-End 2014 Financial Results and Corporate Update

Q3

Biota Pharmaceuticals Reports Third Quarter 2014 Financial Results and Recent Corporate Developments

Q2

Biota Pharmaceuticals Reports Second Quarter 2013 Financial Results and Recent Corporate Developments

Q1

Biota Pharmaceuticals Reports Third Quarter 2014 Financial Results and Recent Corporate Developments

Shareholder Tools

Printed Materials

Printed Materials
Email Alerts

Email Alerts
Download Library

Download Library
RSS

RSS
Print

Print
Share

Share
Search

Search

Facebook
Google
LinkedIn
Twitter
RSS

Global Need

Vaccines
History and Impact

Our Solution

Oral Vaccines
Technology
Vaccine Advantages
Platform Advantages

Pipeline

Research & Development
Norovirus
Influenza
RSV
HPV

About Us

Our Mission
Our Team
Careers
Contact

Investors

© 2018 Vaxart, Inc. All rights reserved.

Technology
- Platform Science
- Advantages
Development
- Clinical Trials
- Pipeline
About
Newsroom
- News Releases
- Publications
INVESTORS
Investor Relations
CONTACT
- Headquarters
- Inquiries

Log In

Username

Password

Remember Me

Lost your password?

Create an account